| Dr Patrick E Owens, DC | |
|
913 W Mckinley Ave, Mishawaka, IN 46545-5511 | |
| (574) 257-0200 | |
| (574) 259-9247 |
| Full Name | Dr Patrick E Owens |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 32 Years |
| Location | 913 W Mckinley Ave, Mishawaka, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396898359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 08001370A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hofferth Chiropractic Center Llc | 6709271786 | 3 |
News Archive
Millions of older adults can start signing up next week for private policies offering Medicare drug and medical coverage for 2020. But many risk wasting money and even jeopardizing their health care due to changes in Medicare's plan finder, its most popular website.
t first glance, America is making great strides toward a medical and cultural shift in its approach to end-of-life care: More and more providers are recognizing the benefits of hospice, more people are dying at home, and many health care organizations are institutionalizing the discussions between providers and patients that would help patients formalize their wishes for end-of-life care through an advance directive. But pull up the curtain on these statistics, and the drama that unfolds tells a very different story. End-of-life care continues to be characterized by aggressive medical intervention and runaway costs (Adamopoulos, 6/3).
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
A team of Australian doctors have identified a new disease and its cure. In their report published in the journal Clinical Infectious Diseases the doctors from The Queensland Institute of Medical Research (QIMR) report a case of a young NSW woman ill for almost a decade with repeated hospitalizations. She is now said to be suffering from a diseases that disabled the signaling processes of her immune system. The diseases is not named yet. Dr Maher Gandhi, head of QIMR's Immunohemotology Laboratory believes there are more cases of this disease. He said this Monday, "I haven't got a name for it other than T-cell signaling defect of which I assume there are quite a few different types… There are no recorded cases of this in the literature. Katie is unique ... I think we're at the tip of the iceberg here."
Teleflex Incorporated announced today that in addition to broad-spectrum antimicrobial protection, the pressure-injectable ARROW PICC with Chloragard Technology provides antithrombogenic protection for at least 30 days.
› Verified 8 days ago
| Provider Name | Hofferth Chiropractic Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1306447313 PECOS PAC ID: 6709271786 Enrollment ID: O20220310001211 |
News Archive
Millions of older adults can start signing up next week for private policies offering Medicare drug and medical coverage for 2020. But many risk wasting money and even jeopardizing their health care due to changes in Medicare's plan finder, its most popular website.
t first glance, America is making great strides toward a medical and cultural shift in its approach to end-of-life care: More and more providers are recognizing the benefits of hospice, more people are dying at home, and many health care organizations are institutionalizing the discussions between providers and patients that would help patients formalize their wishes for end-of-life care through an advance directive. But pull up the curtain on these statistics, and the drama that unfolds tells a very different story. End-of-life care continues to be characterized by aggressive medical intervention and runaway costs (Adamopoulos, 6/3).
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
A team of Australian doctors have identified a new disease and its cure. In their report published in the journal Clinical Infectious Diseases the doctors from The Queensland Institute of Medical Research (QIMR) report a case of a young NSW woman ill for almost a decade with repeated hospitalizations. She is now said to be suffering from a diseases that disabled the signaling processes of her immune system. The diseases is not named yet. Dr Maher Gandhi, head of QIMR's Immunohemotology Laboratory believes there are more cases of this disease. He said this Monday, "I haven't got a name for it other than T-cell signaling defect of which I assume there are quite a few different types… There are no recorded cases of this in the literature. Katie is unique ... I think we're at the tip of the iceberg here."
Teleflex Incorporated announced today that in addition to broad-spectrum antimicrobial protection, the pressure-injectable ARROW PICC with Chloragard Technology provides antithrombogenic protection for at least 30 days.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patrick E Owens, DC 52823 W Cypress Cir, South Bend, IN 46637-4619 Ph: (574) 271-1454 | Dr Patrick E Owens, DC 913 W Mckinley Ave, Mishawaka, IN 46545-5511 Ph: (574) 257-0200 |
News Archive
Millions of older adults can start signing up next week for private policies offering Medicare drug and medical coverage for 2020. But many risk wasting money and even jeopardizing their health care due to changes in Medicare's plan finder, its most popular website.
t first glance, America is making great strides toward a medical and cultural shift in its approach to end-of-life care: More and more providers are recognizing the benefits of hospice, more people are dying at home, and many health care organizations are institutionalizing the discussions between providers and patients that would help patients formalize their wishes for end-of-life care through an advance directive. But pull up the curtain on these statistics, and the drama that unfolds tells a very different story. End-of-life care continues to be characterized by aggressive medical intervention and runaway costs (Adamopoulos, 6/3).
The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders.
A team of Australian doctors have identified a new disease and its cure. In their report published in the journal Clinical Infectious Diseases the doctors from The Queensland Institute of Medical Research (QIMR) report a case of a young NSW woman ill for almost a decade with repeated hospitalizations. She is now said to be suffering from a diseases that disabled the signaling processes of her immune system. The diseases is not named yet. Dr Maher Gandhi, head of QIMR's Immunohemotology Laboratory believes there are more cases of this disease. He said this Monday, "I haven't got a name for it other than T-cell signaling defect of which I assume there are quite a few different types… There are no recorded cases of this in the literature. Katie is unique ... I think we're at the tip of the iceberg here."
Teleflex Incorporated announced today that in addition to broad-spectrum antimicrobial protection, the pressure-injectable ARROW PICC with Chloragard Technology provides antithrombogenic protection for at least 30 days.
› Verified 8 days ago
Michiana Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 236 W Edison Rd Ste 3, Mishawaka, IN 46545 Phone: 574-259-3355 Fax: 574-259-2032 | |
Dr. Austin G King, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 229 Red Coach Dr Ste 6, Mishawaka, IN 46545 Phone: 574-914-4866 | |
John A. Miller Dc Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 535 Lincolnway West, Mishawaka, IN 46544 Phone: 574-255-2268 | |
Blum Family Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 812 W Edison Rd, Mishawaka, IN 46545 Phone: 574-276-4492 | |
Obert Chiropractic Center Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 427 Lincoln Way East, Mishawaka, IN 46544 Phone: 574-258-4100 Fax: 574-258-0477 | |
Dr. Bryan C Glenn, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 535 Lincoln Way W, Mishawaka, IN 46544 Phone: 574-255-1716 | |
Hofferth Chiropractic Center Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 826 W Edison Rd, Mishawaka, IN 46545 Phone: 574-256-1008 |